Skip to main content
. 2020 Nov 7;9(23):9018–9026. doi: 10.1002/cam4.3572

Table 1.

The clinical characteristics of patients

Severance cohort SEER cohort
Patients (n = 398) (n = 10 621)
Mortality events 259 9444
Mean exposure
PM10 (µg/m3) 48.5 ± 14.7 25.6 ± 11.1
CO (ppm) 0.5 ± 0.1 0.5 ± 0.3
Age 56.7 ± 13.5 64.0 ± 13.9
Sex
Male 242 (60.8%) 6 255 (58.9%)
Female 156 (39.2%) 4 366 (41.1%)
Race
Asian 398 (100%) 838 (7.9%)
White 0 (0%) 7 390 (69.6%)
Hispanic 0 (0%) 1 789 (16.8%)
Black 0 (0%) 571 (5.3%)
Others 0 (0%) 33 (0.3%)
Surgery
Yes 398 (100%) 7 632 (71.9%)
No 0 (0%) 2 989 (28.1%)
Chemotherapy
Yes 325 (81.6%) 5 655 (53.2%)
No 73 (18.3%) 4 966 (46.7%)
Radiation mode
Adjuvant radiation 335 (84.2%) 5 592 (52.6%)
No 63 (15.8%) 5 029 (47.4%)
Radiation
Beam radiation 361 (90.7%) 6 970 (65.6%)
No 37 (9.3%) 3 651 (34.4%)

Data are n (%) and mean with standard deviation. Diagnosis of all patients is made as glioblastoma.

PM10: Particulate matter with an aerodynamic diameter less than 10 µm, CO: Carbon monoxide, ppm: Parts per million.